These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32125004)

  • 1. Screening for invasive fungal disease using non-culture-based assays among inpatients with advanced HIV disease at a large academic hospital in South Africa.
    van Schalkwyk E; Mhlanga M; Maphanga TG; Mpembe RS; Shillubane A; Iyaloo S; Tsotetsi E; Pieton K; Karstaedt AS; Sahid F; Menezes CN; Tsitsi M; Motau A; Wadula J; Seetharam S; van den Berg E; Sriruttan C; Govender NP
    Mycoses; 2020 May; 63(5):478-487. PubMed ID: 32125004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and mortality of cryptococcal disease in adults with advanced HIV in an urban tertiary hospital in Sierra Leone: a prospective study.
    Lakoh S; Rickman H; Sesay M; Kenneh S; Burke R; Baldeh M; Jiba DF; Tejan YS; Boyle S; Koroma C; Deen GF; Beynon F
    BMC Infect Dis; 2020 Feb; 20(1):141. PubMed ID: 32059703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu-Natal.
    Drain PK; Kleene JM; Coleman SM; Losina E; Katz JN; Giddy J; Ross D; Freedberg KA; Bassett IV
    HIV Med; 2015 Nov; 16(10):640-4. PubMed ID: 25958770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of a rapid diagnostic assay package for cryptococcosis, histoplasmosis and tuberculosis in people living with HIV in Paraguay.
    Aguilar G; Lopez G; Sued O; Medina N; Caceres DH; Pereira J; Jordan A; Lezcano V; Vicenti C; Benitez G; Samudio T; Perez F
    BMC Infect Dis; 2024 Apr; 24(1):406. PubMed ID: 38627642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative performance of the laboratory assays used by a Diagnostic Laboratory Hub for opportunistic infections in people living with HIV.
    Medina N; Alastruey-Izquierdo A; Mercado D; Bonilla O; Pérez JC; Aguirre L; Samayoa B; Arathoon E; Denning DW; Rodriguez-Tudela JL;
    AIDS; 2020 Sep; 34(11):1625-1632. PubMed ID: 32694415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive patients hospitalized for suspected tuberculosis in Uganda.
    Andama AO; den Boon S; Meya D; Cattamanchi A; Worodria W; Davis JL; Walter ND; Yoo SD; Kalema N; Haller B; Huang L;
    J Acquir Immune Defic Syndr; 2013 Jun; 63(2):189-94. PubMed ID: 23542636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter Cryptococcal Antigen Screening of HIV-Infected Patients in Iran.
    Bandalizadeh Z; Shokohi T; Moosazadeh M; Keikha N; Seyedpor H; Rabie Rudsari M; Babamahmoudi F; Ghasemian R; Mardani M; Javanian M; Soleimanpour S; Sefidgar AA; Shokri M; Gouya MM; Seyedmousavi S
    Curr Microbiol; 2020 Aug; 77(8):1667-1672. PubMed ID: 32296917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point-of-care lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in Uganda.
    Manabe YC; Nonyane BA; Nakiyingi L; Mbabazi O; Lubega G; Shah M; Moulton LH; Joloba M; Ellner J; Dorman SE
    PLoS One; 2014; 9(7):e101459. PubMed ID: 25000489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
    Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
    Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study.
    Gupta-Wright A; Corbett EL; Wilson D; van Oosterhout JJ; Dheda K; Huerga H; Peter J; Bonnet M; Alufandika-Moyo M; Grint D; Lawn SD; Fielding K
    PLoS Med; 2019 Apr; 16(4):e1002776. PubMed ID: 30951533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.
    Rugemalila J; Maro VP; Kapanda G; Ndaro AJ; Jarvis JN
    Trop Med Int Health; 2013 Sep; 18(9):1075-1079. PubMed ID: 23937699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Advanced HIV Disease, Cryptococcal Antigenemia, and Suboptimal Clinical Outcomes Among Those Enrolled in Care in Vietnam.
    Dat VQ; Lyss S; Dung NTH; Hung LM; Pals SL; Anh HTV; Kinh NV; Bateganya M
    J Acquir Immune Defic Syndr; 2021 Dec; 88(5):487-496. PubMed ID: 34446679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reactivity of a Histoplasma capsulatum antigen enzyme immunoassay in urine specimens from persons with emergomycosis in South Africa.
    Maphanga TG; Naicker SD; Gómez BL; Mhlanga M; Mpembe RS; Schwartz IS; Bamford C; Nel J; Govender NP
    Med Mycol; 2021 Jul; 59(7):672-682. PubMed ID: 33330930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.
    Micol R; Lortholary O; Sar B; Laureillard D; Ngeth C; Dousset JP; Chanroeun H; Ferradini L; Guerin PJ; Dromer F; Fontanet A
    J Acquir Immune Defic Syndr; 2007 Aug; 45(5):555-9. PubMed ID: 17577124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of Cryptococcal antigenemia using a finger-prick lateral flow assay in individuals with advanced HIV disease in Santarém Municipality, Brazilian Amazon Basin.
    Assy JGPL; Said RDC; Pinheiro OC; Brandão ADS; Boulware DR; França FOS; Vidal JE
    Med Mycol; 2021 Sep; 59(9):909-915. PubMed ID: 33908611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of fungal opportunistic infections in people living with HIV from Guatemala and El Salvador.
    Forno D; Samayoa B; Medina N; Arathoon E; Mejia CR; Gordillo R; Cedillos R; Rodas J; Ahlquist Cleveland A; Chiller T; Caceres DH
    Mycoses; 2021 Dec; 64(12):1563-1570. PubMed ID: 34536307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review of Prevalence of Histoplasma Antigenuria in Persons with HIV in Latin America and Africa.
    Sekar P; Hale G; Gakuru J; Meya DB; Boulware DR; Ellis J; Nalintya E; Bahr NC; Rajasingham R
    Emerg Infect Dis; 2024 Aug; 30(8):1523-1530. PubMed ID: 39043389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptococcal antigenemia and associated risk factors among ART-naïve and ART-experienced HIV-infected peoples at selected health institutions of Mekelle, Northern Ethiopia.
    Hailu K; Niguse S; Hagos K; Abdulkader M
    Microbiologyopen; 2019 Jun; 8(6):e00746. PubMed ID: 30277315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis.
    Rajasingham R; Govender NP; Jordan A; Loyse A; Shroufi A; Denning DW; Meya DB; Chiller TM; Boulware DR
    Lancet Infect Dis; 2022 Dec; 22(12):1748-1755. PubMed ID: 36049486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial.
    Peter JG; Zijenah LS; Chanda D; Clowes P; Lesosky M; Gina P; Mehta N; Calligaro G; Lombard CJ; Kadzirange G; Bandason T; Chansa A; Liusha N; Mangu C; Mtafya B; Msila H; Rachow A; Hoelscher M; Mwaba P; Theron G; Dheda K
    Lancet; 2016 Mar; 387(10024):1187-97. PubMed ID: 26970721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.